Login / Signup

Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City.

Medha BarbhaiyaMarianna B FreyJonah M LevineGregory J VitoneLindsay LallyMichael D LockshinVivian P BykerkCandace H FeldmanLisa A Mandl
Published in: Clinical rheumatology (2022)
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • rheumatoid arthritis
  • systemic lupus erythematosus